Learn more
Log in
0 followers
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.
Industries
Headquarters
Stage
Employees
Links
Thomas Cavanagh
12 members
3 members
Cartesian Therapeutics
1 follower
Scenic Biotech
Volt
4 followers
99home
WeDoCRM
Discover companies